New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A possible cure for allergies

A possible cure for allergies

by Swiss Institute of Allergy and Asthma Research (SIAF)Scientists from Switzerland, Japan and the US discovered that mast cells are not only “bad guys” that initiate the allergic reaction, but also h
Immunology & Rheumatology March 25,2024
A possible cure for allergies

A possible cure for allergies

by Swiss Institute of Allergy and Asthma Research (SIAF)Scientists from Switzerland, Japan and the US discovered that mast cells are not only “bad guys” that initiate the allergic reaction, but also h
Immunology & Rheumatology March 25,2024
How an emerging drug class dampens harmful immune reactions

How an emerging drug class dampens harmful immune reactions

by Angelika Jacobs,University of BaselOverview of complement mechanisms and compstatin-based inhibitor development.aSimplified scheme of the complement cascade with major effector fu
Immunology & Rheumatology March 25,2024
How an emerging drug class dampens harmful immune reactions

How an emerging drug class dampens harmful immune reactions

by Angelika Jacobs,University of BaselOverview of complement mechanisms and compstatin-based inhibitor development.aSimplified scheme of the complement cascade with major effector fu
Immunology & Rheumatology March 25,2024
New type of treatment could reawaken immune response against prostate cancer

New type of treatment could reawaken immune response against prostate cancer

by Institute of Cancer ResearchA single prostate cancer cell. Credit:Anne Weston, Francis Crick Institute, CC BY-NCTargeting a molecule on the surface of immune cells could offer an excitin
Nephrology & Urology March 25,2024
New type of treatment could reawaken immune response against prostate cancer

New type of treatment could reawaken immune response against prostate cancer

by Institute of Cancer ResearchA single prostate cancer cell. Credit:Anne Weston, Francis Crick Institute, CC BY-NCTargeting a molecule on the surface of immune cells could offer an excitin
Nephrology & Urology March 25,2024
BrainSwarming, blockchain, and bioethics: Applying engineering techniques to problems in health care and biomedicine

BrainSwarming, blockchain, and bioethics: Applying engineering techniques to problems in health care and biomedicine

JANUARY 12, 2024byNational University of SingaporeAn example of BrainSwarming: BrainSwarming graphs were designed as a means of visualizing problem-solving and facilitating simultaneous idea gen
Breakthroughs March 25,2024
BrainSwarming, blockchain, and bioethics: Applying engineering techniques to problems in health care and biomedicine

BrainSwarming, blockchain, and bioethics: Applying engineering techniques to problems in health care and biomedicine

JANUARY 12, 2024byNational University of SingaporeAn example of BrainSwarming: BrainSwarming graphs were designed as a means of visualizing problem-solving and facilitating simultaneous idea gen
Breakthroughs March 25,2024
Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

FEBRUARY 27, 2024by Juntendo University Research Promotion CenterGPR30 in brain microvasculature responds to bicarbonate, and its deficiency protects against ischemia-reperfusion injury, reducing neur
Breakthroughs March 25,2024
Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

Innovative therapies for ischemic stroke: Novel bicarbonate-sensing G protein-coupled receptor shows promise

FEBRUARY 27, 2024by Juntendo University Research Promotion CenterGPR30 in brain microvasculature responds to bicarbonate, and its deficiency protects against ischemia-reperfusion injury, reducing neur
Breakthroughs March 25,2024
Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl
Oncology March 25,2024
Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

Treatment of aggressive breast cancer: Discovery of a new protein involved in the development of metastases

JANUARY 31, 2024byCNRSIllustration of the invasive capacity of breast cancer cells with (on) and without (off) SMYD2 expression; Scale bar: 10µm. Credit: Casanova et al.A protein found abundantl
Oncology March 25,2024
Parkinson's disease clinical trial tests exercise regimen to improve movement

Parkinson's disease clinical trial tests exercise regimen to improve movement

MAY 17, 2023by Erik Robinson,Oregon Health & Science UniversityLinda Cherney demonstrates an OHSU training protocol designed to improve the ability to turn for people with Parkinson’s diseas
Breakthroughs March 25,2024
Parkinson's disease clinical trial tests exercise regimen to improve movement

Parkinson's disease clinical trial tests exercise regimen to improve movement

MAY 17, 2023by Erik Robinson,Oregon Health & Science UniversityLinda Cherney demonstrates an OHSU training protocol designed to improve the ability to turn for people with Parkinson’s diseas
Breakthroughs March 25,2024
Special RNA shown to suppress the formation of breast cancer cells

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom
Oncology March 25,2024
Special RNA shown to suppress the formation of breast cancer cells

Special RNA shown to suppress the formation of breast cancer cells

JANUARY 16, 2024by Sebastian Hollstein,Friedrich Schiller University of JenaCredit:Cell Reports(2024). DOI: 10.1016/j.celrep.2023.113644Breast cancer is the most common cancer in wom
Oncology March 25,2024
A new treatment reduces inflammation in multiple sclerosis mice models

A new treatment reduces inflammation in multiple sclerosis mice models

by Autonomous University of BarcelonaMaR1 reduces pro-inflammatory cytokines in the spinal cord of EAE mice. Plot showing the fold change in cytokine protein levels of different cytokines in the
Neurology March 25,2024
A new treatment reduces inflammation in multiple sclerosis mice models

A new treatment reduces inflammation in multiple sclerosis mice models

by Autonomous University of BarcelonaMaR1 reduces pro-inflammatory cytokines in the spinal cord of EAE mice. Plot showing the fold change in cytokine protein levels of different cytokines in the
Neurology March 25,2024
Immune system's moonlighters point the way to a new therapeutic target

Immune system's moonlighters point the way to a new therapeutic target

FEBRUARY 20, 2024byCold Spring Harbor LaboratoryGraphical abstract. Credit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.01.007Our immune system is remarkably powerful. It quickly
Immunology & Rheumatology March 25,2024
Immune system's moonlighters point the way to a new therapeutic target

Immune system's moonlighters point the way to a new therapeutic target

FEBRUARY 20, 2024byCold Spring Harbor LaboratoryGraphical abstract. Credit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.01.007Our immune system is remarkably powerful. It quickly
Immunology & Rheumatology March 25,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com